Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up.
about
Combined DTP-HBV vaccine versus separately administered DTP and HBV vaccines for primary prevention of diphtheria, tetanus, pertussis, and hepatitis BBooster dose vaccination for preventing hepatitis BBooster dose vaccination for preventing hepatitis BBooster dose vaccination for preventing hepatitis BHepatitis B and the need for a booster doseHBV vaccination status and response to hepatitis B vaccine among Iranian dentists, correlation with risk factors and preventive measuresA Longitudinal Hepatitis B Vaccine Cohort Demonstrates Long-lasting Hepatitis B Virus (HBV) Cellular Immunity Despite Loss of Antibody Against HBV Surface AntigenAntibody Levels and Protection After Hepatitis B Vaccine: Results of a 30-Year Follow-up Study and Response to a Booster Dose.A cohort study to evaluate persistence of hepatitis B immunogenicity after administration of hexavalent vaccines.The Alaska Area Specimen Bank: a tribal-federal partnership to maintain and manage a resource for health research.Increasing incidence of recent hepatitis D virus infection in HIV-infected patients in an area hyperendemic for hepatitis B virus infection.Hepatitis B virus: where do we stand and what is the next step for eradication?Antibody responses during hepatitis B viral infection.Immunogenicity of recombinant hepatitis B vaccine: comparison of two different vaccination schedulesTwenty years of universal vaccination against hepatitis B in Italy: achievements and challenges.Hepatitis B vaccine in celiac disease: yesterday, today and tomorrow.Age-specific prevalence of hepatitis B virus infection in young pregnant women, Hong Kong Special Administrative Region of China.The timing of hepatitis B virus (HBV) immunization relative to human immunodeficiency virus (HIV) diagnosis and the risk of HBV infection following HIV diagnosis.Partial delipidation improves the T-cell antigenicity of hepatitis B virus surface antigen.Female hepatology: favorable role of estrogen in chronic liver disease with hepatitis B virus infection.Durability of antibody response against hepatitis B virus in healthcare workers vaccinated as adults.Seroprevalence of hepatitis B virus among adults at high risk for HIV transmission two decades after implementation of nationwide hepatitis B virus vaccination program in Taiwan.HBV vaccine efficacy and detection and genotyping of vaccineé asymptomatic breakthrough HBV infection in Egypt.The long-term immunogenicity of recombinant hepatitis B virus (HBV) vaccine: contribution of universal HBV vaccination in ItalyRate of acquired immunity in dental students after hepatitis B vaccinationRisk of hepatitis B virus reactivation in rheumatoid arthritis patients undergoing biologic treatment: Extending perspective from old to newer drugs.Let It "B"? The role of Hepatitis B universal vaccination among italian problematic drug users.Bicistronic woodchuck hepatitis virus core and gamma interferon DNA vaccine can protect from hepatitis but does not elicit sterilizing antiviral immunityPrevalence of National Responsiveness to HBV Vaccine After 22 Years of Iranian Expanded Program on Immunization (EPI): A Systematic Review and Meta-Analysis StudyThe one year effects of three doses of hepatitis B vaccine as a booster in anti-HBs-negative children 11-15 years after primary immunization; China, 2009-2011.The response of hepatitis B vaccination on seronegative adults with different vaccination schedules.Age-dependent decrease of anti-HBs titers and effect of booster doses using 2 different vaccines in Palestinian children vaccinated in early childhood.Comparison of the effect of two different doses of recombinant hepatitis B vaccine on immunogenicity in healthy adults.Effectiveness of hepatitis B virus vaccination program in Egypt: Multicenter national project.Impact of universal vaccination against hepatitis B: the italian model.Optimal vaccination program for healthy adults in China.24 year outcomes of hepatitis B vaccination in Hangzhou, China.CD4+ T Cells Are Not Required for Suppression of Hepatitis B Virus Replication in the Liver of Vaccinated Chimpanzees.Identification of occult hepatitis B virus (HBV) infection and viral antigens in healthcare workers who presented low to moderate levels of anti-HBs after HBV vaccination.Persistence of Anti-HBs Among Palestinian Medical Students After 18 - 22 Years of Vaccination: A Cross-Sectional Study.
P2860
Q24236040-E939DF00-9438-486E-9515-D37F39FBF704Q24236587-F0BC2D06-2DE3-49A2-BC82-C892107516BFQ24241577-486E9A60-463E-4470-AEF5-89991936E13AQ26471510-1E835D90-E792-43F6-BA25-F6ED3583D08CQ28239937-F97D1F0C-85E9-458F-9FD5-5B8D2323BAA6Q28388849-73D26E4B-AEC1-4959-9ACA-CFD3918C6E98Q30152118-9675A600-5952-4E7B-85D5-8D9CEF0B2A3BQ30196893-70FA5806-353A-4BFF-AB45-73BDB156FF5CQ33355656-AAA29F39-00AA-4CFC-B729-D60F74DD7C9AQ33455592-06D01281-C40A-4D4B-86E6-91F66796F98DQ33813200-55888EC5-D7CB-40B8-A070-9B8453C901EEQ33958764-97654592-F4AE-43E1-AD77-A1D7590A2ACDQ33981600-44B285EE-D842-4080-872D-984D08D128E3Q34021203-2025D8C3-2027-4CC9-B9C4-AA0ADD94D230Q34074115-58A41D9A-E0AE-4C90-9953-968E1EC1EFF4Q34329062-E7A885EA-A76F-4141-B837-A5D6A358DB76Q34460388-F30C1F2B-3360-4F06-A750-24386DCA58F1Q34514263-7A583452-F7C0-4DF9-A634-05CF09E95AA0Q34545711-41CA1215-6B6D-42D9-8BEC-D2FABFA4FEE4Q34606036-94F70FEC-4496-4261-A9C6-F972540A9AA3Q35055166-18915CC1-E6AF-4E68-9A02-C46C95E5822DQ35108823-CD6A0F82-68E8-4F37-8120-8A71676BC18DQ35174813-C94E25C2-FB8E-479B-A1DA-091B2CBEB0D4Q35224155-C02EBCBF-25E1-4C72-9737-A547CF2E67E3Q35224697-D1CF8A9B-B590-43EB-A7E1-67B09A072BAAQ35237316-E7B0E2C6-B6B4-4219-8B4A-7899873895D9Q35539786-2636C39C-A16F-49B6-857A-CF6F3760B37EQ35634911-8FEBB25E-71B5-4A04-AA5C-A4F70229F585Q35671639-C2F7D6CA-134A-40A0-85E7-3E27599F30A0Q35886836-7FCD5178-1708-44DF-9673-16927DCFAE66Q35887060-A5390C04-3975-4775-9558-A832F9093D4CQ35887238-4389C820-A30D-4F6B-B581-D55A2BB9C100Q35887572-0EBC4EAC-C520-40ED-91D3-178B8DE3F4E8Q36138640-0E00541C-1784-4832-B003-5A58A48F1DD4Q36220189-4BD16EA7-AB5C-49B1-A45B-2B1670978A58Q36256281-99D0E9F7-4DD9-4FEF-BEFC-BDB9B1F90E27Q36256369-013F3597-EC73-4FB8-816C-74E1806129C2Q36365279-221FB7D6-62EC-49D3-9E49-8758D3DAA932Q36404398-8742B427-FEF6-4528-8592-F58FB077D23FQ36474957-BAD94165-E194-4278-B2A6-43B47148F3BC
P2860
Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Antibody levels and protection ...... esults of a 15-year follow-up.
@en
Antibody levels and protection ...... esults of a 15-year follow-up.
@nl
type
label
Antibody levels and protection ...... esults of a 15-year follow-up.
@en
Antibody levels and protection ...... esults of a 15-year follow-up.
@nl
prefLabel
Antibody levels and protection ...... esults of a 15-year follow-up.
@en
Antibody levels and protection ...... esults of a 15-year follow-up.
@nl
P2093
P1476
Antibody levels and protection ...... esults of a 15-year follow-up.
@en
P2093
Alan J Parkinson
Brian J McMahon
Carolyn Zanis
Harold S Margolis
Helen Peters
Kenneth M Petersen
Lisa R Bulkow
Marina Khristova
Omana Nainan
P304
P356
10.7326/0003-4819-142-5-200503010-00008
P407
P577
2005-03-01T00:00:00Z